Disclosed is a human VEGF2 polypeptide and DNA (RNA) encoding such VEGF2 polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist against such polypeptide. Also disclosed is a method of using such polypeptide for stimulating wound healing and for vascular tissue repair. Also provided are methods of using the antagonists to inhibit tumor growth, inflammation and to treat diabetic retinopathy, rheumatoid arthritis and psoriasis. Diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein in a sample derived from a host are also disclosed.

 
Web www.patentalert.com

< Vesicular monoamine transporter gene therapy in parkinson's disease

< Interleukin-1.beta. converting enzyme like apoptotic protease-6

> Hypohidrotic ectodermal dysplasia genes and proteins

> Composition and its therapeutic use

~ 00292